Skip to content

Participant Login Provider Login Provider Signup Support

Home
>Resources

Discover How Helix is Changing the World of Healthcare

Resources Hub

Get in touch

Weaving Genomics into the Fabric of Healthcare

Contact us:

Customer Support: (844) 211 2070 Monday - Friday: 6 AM – 6 PM (Pacific)

© 2016-2025 Helix, Inc. All rights reserved.

Helix, the Helix logo, Exome+, and Sequence Once, Query Often are trademarks of Helix, Inc.

Resources

Blog
Research
All Resources

Who we serve

Health Systems
Life Sciences
Public Health

Company

About Us
News
Press Releases
Careers

Contact Us

Partnerships
Participant Support

Participant Support

Contact Support
Help Center

Privacy Notice
Terms of Service
Notice of Privacy Practices
Consumer Health Privacy Policy
Accessibility
Your Privacy Choices

CLIA #05D2117342
CAP #9382893

The Latest Content From Helix

Recent Blog Posts

View All Blog Posts

Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care

From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.

By James Lu, MD, PhD, CEO and Co-Founder of Helix

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Recent Press Releases

View All Press Releases

Helix GenoSphere™ Launches MASH-Enriched Cohort of Over 17,000 Linked Clinico-Genomic Records to Accelerate Drug Discovery and Development

October 15, 2025

Helix to Present New Population-Scale Genomic Research at ASHG 2025 Annual Meeting

October 7, 2025

Parkview expands DNA Insights program to the public

September 9, 2025

Recent Videos

View All Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

Population Genomic Screening and Improved Lipid Management in Patients With Familial Hypercholesterolemia

November 5, 2025

2

Published Research

From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence

August 15, 2025

3

Published Research

Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort

4

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

5

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Recent Whitepapers

View All Whitepapers

Performance and Applications of Helix Exome+^® Assay

October 30, 2025

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

January 3, 2024

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

October 11, 2023

The Latest Content From Helix

Recent Blog Posts

View All Blog Posts

Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care

From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.

By James Lu, MD, PhD, CEO and Co-Founder of Helix

Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels

GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward

Recent Press Releases

View All Press Releases

Helix GenoSphere™ Launches MASH-Enriched Cohort of Over 17,000 Linked Clinico-Genomic Records to Accelerate Drug Discovery and Development

October 15, 2025

Helix to Present New Population-Scale Genomic Research at ASHG 2025 Annual Meeting

October 7, 2025

Parkview expands DNA Insights program to the public

September 9, 2025

Recent Videos

View All Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

Population Genomic Screening and Improved Lipid Management in Patients With Familial Hypercholesterolemia

November 5, 2025

2

Published Research

From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence

August 15, 2025

3

Published Research

Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort

4

Published Research

Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project

5

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Recent Whitepapers

View All Whitepapers

Performance and Applications of Helix Exome+^® Assay

October 30, 2025

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

January 3, 2024

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

October 11, 2023

Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

Research

Feb 6, 2021

Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

MEDRXIV

Helix Launches a COVID-19 Viral Surveillance Dashboard to Track Emergence and Prevalence of New SARS-CoV-2 Variants

Press Releases

Jan 21, 2021

Helix Launches a COVID-19 Viral Surveillance Dashboard to Track Emergence and Prevalence of New SARS-CoV-2 Variants

Dr. James Lu Interview on New COVID-19 variants discovered in the U.S.

News

Jan 15, 2021

Dr. James Lu Interview on New COVID-19 variants discovered in the U.S.

Critical Mention

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

News

Jan 15, 2021

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

Business Wire

Helix Obtains FDA Authorization for Exome Sequencing Platform, Alzheimer's Disease Risk Test

News

Jan 11, 2021

Helix Obtains FDA Authorization for Exome Sequencing Platform, Alzheimer's Disease Risk Test

GenomeWeb

Helix Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

Press Releases

Jan 11, 2021

Helix Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

Update on the Helix, Illumina surveillance program: B.1.1.7 variant of SARS-CoV-2, first identified in the UK, spreads further into the US

Blog

Jan 11, 2021

Update on the Helix, Illumina surveillance program: B.1.1.7 variant of SARS-CoV-2, first identified in the UK, spreads further into the US

SARS-CoV-2 UK variant (B.1.1.7) in the US: Four cases identified in Florida and California

Blog

Dec 31, 2020

SARS-CoV-2 UK variant (B.1.1.7) in the US: Four cases identified in Florida and California

Is the new SARS-CoV-2 UK variant (B.1.1.7) already in the US? Maybe.

Blog

Dec 23, 2020

Is the new SARS-CoV-2 UK variant (B.1.1.7) already in the US? Maybe.

Page 34